rxstat › Shortages › Ethinyl Estradiol Desogestrel

Ethinyl Estradiol Desogestrel shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ethinyl Estradiol Desogestrel products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 20, 2026.
Products affected
1 / 10
In shortage since
Apr 15, 2026
Est. full return
Aug 20, 2026
Reports on file
33
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APRI 28
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317206 · since Apr 15, 2026, est. end Aug 20, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 28
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410257 · ended Apr 16, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410249 · ended Apr 2, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410249 · ended Aug 14, 2025 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410249 · ended Jul 11, 2025 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 28
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410257 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
Resolved
APRI 28
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317206 · ended Dec 1, 2022 · Disruption of the manufacture of the drug.
Resolved
APRI 21
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317192 · ended Dec 1, 2022 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410249 · ended Nov 4, 2022 · Delay in shipping of the drug.
Resolved
FREYA 28
0.15MG 0.03MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02396610 · ended Oct 26, 2022 · Other (Please describe in comments)
Resolved
FREYA 21
0.03MG 0.15MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02396491 · ended Oct 24, 2022 · Other (Please describe in comments)
Resolved
MIRVALA 28
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410257 · ended Jan 14, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 33 reports. All reports are on file with Health Canada.

What's happening

Ethinyl Estradiol Desogestrel is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ethinyl Estradiol Desogestrel is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AA).

Recent changes

Common questions

When will Ethinyl Estradiol Desogestrel be back in stock in Canada?

The latest manufacturer estimate is Aug 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ethinyl Estradiol Desogestrel in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (hormonal contraceptives for systemic use)

Partial shortageDrospirenone Ethinyl Estradiol1 of 9 reported products affected · est. return Aug 10, 2026Partial shortageEthinyl Estradiol Levonorgestrel3 of 18 reported products affectedPartial shortageEthinyl Estradiol Levonorgestrel Ethinyl Estradiol1 of 1 reported products affectedPartial shortageEthinyl Estradiol Norethindrone4 of 10 reported products affected · est. return Mar 19, 2027Partial shortageNorethindrone1 of 4 reported products affected · est. return Aug 10, 2026Partial shortageNorgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol2 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.